Citation
(2010), "Alzheimer's disease", Nutrition & Food Science, Vol. 40 No. 6. https://doi.org/10.1108/nfs.2010.01740fab.007
Publisher
:Emerald Group Publishing Limited
Copyright © 2010, Emerald Group Publishing Limited
Alzheimer's disease
Article Type: Food facts From: Nutrition & Food Science, Volume 40, Issue 6.
Ablynx (Euronext Brussels: ABLX) announced that Boehringer Ingelheim has selected a Nanobody lead candidate for further development for the treatment of Alzheimer's disease. This is the first lead candidate emerging from the Alzheimer's disease collaboration between Ablynx and Boehringer Ingelheim, and will result in a €2 million milestone payment to Ablynx.